Within a single cell -the minimum unit of every living organism -many millions of different types of molecule are working to maintain the cell, to promote its replication, or even to cause its suicide. The bioprocesses conducted within the cell are chemical reactions that proceed under the control of a highly organized network of molecular interactions between relevant biomolecules.
DNA, as shown in Figure 1 .1, is a polyester made through condensations between a deoxyribose as the diol unit and a phosphoric acid as the bivalent acid unit. The negatively charged phosphates make the DNA molecule water-soluble. Due to the asymmetric arrangement of the 5 -OH and 3 -OH groups on the deoxyribose unit, DNA is a directional biopolymer. The chain end with the 5 -OH or 5 -O-phosphate unit is called the 5 -end, while the end with the 3 -OH or 3 -O-phosphate unit is called the 3 -end.
DNAs are characterized by the sequences of base groups that are linked to the deoxyribose units. There are four types of base group: adenine (A), thymine (T), guanine (G) and cytosine (C). Different DNAs carry different sequences of nucleobases that are read from the 5 end to the 3 end.
Nucleobases form hydrogen bonds between A and T and between G and C exclusively, as shown in Figure 1 .2. With few exceptions, the A-T/G-C pairing is a basic rule common to all organisms. As a result of this exclusive pairing, a DNA strand that has a 5 -A-T-G-C-A-T-G-C-3 sequence, for instance, forms a stable hybrid only with a DNA strand of a 5 -G-C-A-T-G-C-A-T-3 sequence. Note that the two DNA strands hybridize in an antiparallel manner, as shown in Figure 1 .3. The two DNA strands that carry fully matched sequences are called a complementary pair. Watson and Crick discovered that the complementary DNA strands form a double-helical structure, as shown in Figure 1 .4.
As the base sequences are kept safely inside the cylinder of negatively charged, doublehelical chains, the genetic information has been stored securely for many generations in the form of the sequences of nucleobases. The double-helical structure, however, is not absolutely stable, and unfolds at high temperatures or by the action of an enzyme called a helicase.
Replication of DNA
In order for genetic information to be transferred to the next generation, DNA must first be copied to replicate itself. DNA replication is conducted with an aid of an enzyme called DNA polymerase. The basic chemistry of the replication proceeding inside the enzyme is illustrated in Figure 1 .5.
First, the double-helical chain is unfolded and one of the DNA chains is copied to create its complementary chain. The monomer units involved in this polymerization are activated nucleotide units, dATP, dTTP, dGTP and dCTP. The triphosphate unit of the dNTP units is very susceptible to the attack of the 3 -OH group, and forms a diphosphate linkage. Guided by the enzyme, a correct monomer binds to the template DNA chain and reacts with the 3 -OH group of the growing chain. In this way, the new chain grows from the 5 end to the 3 end.
Transcription from DNA to RNA
Although the stable and inflexible DNA double-helical structure is suitable for the storage of genetic information, its large size necessitates that a smaller, more flexible biopolymer, is used to translate the stored genetic code into proteins. To that end, the base sequences are copied into another type of biopolymer nucleic acid, specifically ribonucleic acid (RNA). RNA is structurally different from DNA in two ways (see the left part of Figure 1 .6). The first difference is that an OH group is attached to the 2 C atom of deoxyribose unit; the 2 -OH derivative is called a ribose unit. The second difference is that a methyl group is removed from the thymine unit to make a uracil unit, U. The introduction of a 2 -OH group causes a small conformational change on the ribose unit such that the RNA chain will favor single-stranded conformations. The single-stranded RNAs, however, often assume an intramolecularly hydrogen-bonded structure, such as a stem-loop structure (see Figure 1 .6, right). Similar to DNA replication, one of the double-stranded DNA chains is copied to a single RNA chain of the complementary nucleobase sequence, except for the alteration of T to U, as shown schematically in Figure 1 .7. This procedure is known the transcription process, and is conducted with an enzyme called RNA polymerase. The chemistry of transcription is similar to the replication process, and the monomers are ATP, UTP, GTP and CTP.
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Translation of the Nucleobase Sequence of mRNA to the Amino Acid Sequence of Protein
The information stored in the form of a nucleobase sequence along an RNA chain is translated to an amino acid sequence of a protein, as shown schematically in Figure 1 .8. RNAs that serve the translation process are called messenger RNAs (mRNAs). In the translation process, three consecutive nucleobases on a mRNA are taken together and converted to a specific amino acid. The set of three nucleobases is called a codon. As four possibilities (A, U, G and C) exist for each nucleobase, there are 4 3 = 64 different codons. Adapter molecules bridge the codons and the amino acids. A class of small RNAs, called transfer RNAs (tRNAs), serve as those adapters. The base sequence of a yeast tRNA that bridges between a codon UUC and an amino acid, phenylalanine, is shown in Figure 1 .9.
tRNAs commonly have stem-loop structures with three loops and four stems. Among the loops, the anticodon loop contains three consecutive nucleobases that bond specifically to its complementary codon; thus, a tRNA of a specific anticodon binds to a specific codon on an mRNA. If a particular amino acid is linked to a specific tRNA of specific anticodon, the amino acid will be called up by the codon. In this way, the sequence of nucleobases is translated to the sequence of amino acids. 
The Codon Table
A list that correlates between the base sequences of codons and the amino acids is called a codon table (see Figure 1 .10). The codon table is common to almost all organisms on the Anticodon An amino acid will be covalently bound here. Because 64 codons correspond to 20 amino acids, there is redundancy in the use of codons. For example, phenylalanine is coded by both UUU and UUC, while leucine is coded by six codons. It must be noted that UUA, UAG and UGA do not correspond to any amino acid, and so are called stop codons. Thus, if they appear on an mRNA, the protein synthesis will cease. Compared with the stop signal, the mechanism of the start of protein synthesis is a little complicated, and is different in bacteria and eukaryotic cells. In prokaryotic bacteria, mRNA has a special region, called the Shine-Dalgano (SD) sequence, and the first AUG codon after the SD sequence works as the start codon. In eukaryotic cells, the first AUG codon from the 5 terminal of an mRNA is the start codon. In any case, the N-terminal amino acid of a newly synthesized protein will be methionine.
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The Twenty Amino Acids
The types of amino acid that constitute proteins, again, are common to all organisms; the chemical structures of the 20 amino acids are listed in Figure 1 Figure 1 .11 Amino acids that constitute proteins side groups, while the second group (Ser, Cys, Thr, Asn and Gln) has nonionic polar side groups. The third group (Asp and Glu) has anionic side groups, and the fourth (Arg and Lys) has cationic groups. The fifth group (His, Phe, Tyr and Trp) has aromatic groups. Protein conformations depend on the combination of the different groups along a polypeptide chain, such as water-soluble globular proteins, membrane-penetrating hydrophobic proteins, and so on.
Aminoacylation of tRNA
The process of linking a specific amino acid to a specific tRNA is called the aminoacylation of tRNA, and is governed by a single enzyme, aminoacyl tRNA synthetase (ARS) for each amino acid. For example, phenylalanine (Phe) is charged onto a tRNA that has an anticodon UUU or UUC, with an enzyme PheRS. Aminoacylation consists of two stages, as illustrated in Figure 1 .12 (top). First, a particular amino acid is bound to its specific ARS and is activated with adenosine triphosphate (ATP) to form an adenylated amino acid. In the second stage, a particular tRNA is bound to its specific ARS that holds the adenylated amino acid. The latter then reacts with the 3 -terminal OH group of the tRNA to form an ester linkage between the amino acid and the tRNA.
ARS is a 'super' enzyme that recognizes three different substrates: ATP, a specific amino acid, and a specific tRNA. In the first stage of aminoacylation, the formation of an adenylated amino acid activates an amino acid. The mixed anhydride of carboxylic acid and phosphoric acid of the adenylated amino acid is very susceptible to water. Inside the enzyme, however, the mixed anhydride is kept safe, until a correct tRNA is bound in proximity so as to induce the aminoacylation. The accuracy of the ARS/amino acid/tRNA selection is very high, and the probability of an erroneous aminoacylation is less than 10 −4 .
Protein Synthesis in Ribosomes
Codon/anticodon pairing consists of only three base pairs, and is not strong enough to hold the tRNA/mRNA hybrids. Consequently, aminoacyl tRNAs do not bind to mRNA in solution, even if they have correct anticodons against the codons on mRNA. The codon/anticodon pairing takes place only inside a huge molecular assembly, called a ribosome, which is constructed from RNAs and proteins (Figure 1.13) . Inside a ribosome, there are two 'rooms' -one for an aminoacyl tRNA (A site) and the other for a tRNA linked with the growing peptide (P site). There are also two 'tunnels' -one for an mRNA and the other for the growing peptide. Protein synthesis proceeds inside a ribosome, as illustrated in Figures 1.13 and 1 .14. After a tRNA has been aminoacylated with the relevant ARS, it is brought into the A site of the ribosome by the aid of an enzyme, elongation factor-Tu (EF-Tu). In the A site, the aminoacyl tRNA is oriented to locate its amino group in close proximity to the C-terminal ester group of the growing peptide on the tRNA in the P site (see Figure 1 .14, top, left). The amino group then attacks the ester group, leading to the formation of a new peptide bond. As the result of this peptide bond formation, the growing peptide transfers to the tRNA in the A site (peptidyl transfer; see Figure 1 .14, top, right). The A site tRNA, carrying the growing peptide, is then translocated to the P site, leaving the A site vacant (Figure 1 .14, bottom). Finally, the next aminoacyl tRNA will be brought into the vacant A site. This polymerization cycle will be repeated until one of stop codons (UAA, UAG and UGA) 
The Total Process of Protein Synthesis: 'The Central Dogma'
The entire bioprocess -from DNAs to proteins and from amino acids to polypeptides -is summarized in Figure 1 .15. The protein biosynthetic process is essentially the same in all organisms and is referred to as the 'central dogma', although several important differences exist between bacterial and eukaryotic systems.
The central dogma consists of two paths: one path for a flow of information from the nucleobase sequences of DNAs to the amino acid sequences of proteins, and a second path for a flow of materials from amino acids to polypeptides. It is counterintuitive that all organisms from bacteria, to plants and to animals, share essentially the same biosynthetic mechanism, due to the obvious differences in their physical appearances. As no organism lives with only 18 types of amino acid or with six types of nucleobase, it can be deduced that all living organisms are descendants from a single common cell that was comprised of 20 types of amino acid, four types of nucleobase and, essentially, the same protein-biosynthesizing system, as shown in Figure 1 .15. Currently, a number of chemists are attempting to expand the central dogma and to create a 'new life' that lives with more than 20 types of amino acid or with more than four types of nucleobase.
Proteins: Polypeptides with a Variety of Specialty Side Groups that are Spatially Arranged to Achieve Biological Functions
Proteins are constructed from polypeptide chains along which a variety of functional groups are rationally arranged to play individual roles. Unlike most synthetic polymers, the polypeptide main chain is relatively stiff; such rigidity is due to amide groups favoring a planar and trans geometry resulting from the partial shift of an electron from nitrogen to oxygen (Figure 1.16) . Moreover, because of the electronic polarization, the N-H group is an excellent proton donor, while the oxygen atom, in turn, is an excellent proton acceptor. As a result, the amide groups in a polypeptide chain are able to build a strong hydrogen bond network with each other. If the hydrogen bonds were formed between amide groups that are separated by every three α-carbon atoms along a single polypeptide chain, then the latter will take a righthanded α-helical conformation. If hydrogen bonds form to assemble several antiparallelrunning chains together, then the polypeptide chains will assume a β-sheet structure.
By combining these structural motifs, such as α-helices and β-sheets, proteins may take a variety of main chain conformations. As an example, a main chain structure of a bacterial phenylalanyl tRNA synthetase (PheRS) is shown in Figure 1 .17. The α-helical parts of the main chain are shown in dark gray, and the β-sheet parts in light gray. The bound phenylalanine is presented by a space-filling model. As amino acid side groups appear in every three atoms along a polypeptide chain, severe crowding is expected between them. Thus, the orientations of the side groups are very constrained and, if they were properly arranged, the side groups would form a threedimensional space for the effective binding of external molecules, or build a functional region for achieving enzymatic reactions. Figure 1 .17 shows how a substrate (phenylalanine, shown by the space-filling model) is bound to its binding site that is made of constrained orientations of the side groups located nearby.
Genetic Engineering
The central dogma tells us that the amino acid sequences of proteins are determined solely by the nucleobase sequences of protein-coding DNA. Therefore, if new DNA can be synthesized, or if some nucleobases can be substituted with other nucleobases, and the new DNA is introduced into the protein-biosynthesizing system, then new or partially mutated proteins will be created. This technique is known as 'genetic engineering', and is widely applied in agricultural, pharmaceutical and medical fields.
In order to introduce new or mutated DNAs into living organisms, for example Escherichia coli, a small cyclic double-helical DNA, called a plasmid, is used as the transporter or a vector of the gene (Figure 1.18) . The plasmid contains functional units, as depicted in the figure. The new gene is inserted into the protein-coding region by cutting off a portion by restriction enzymes, EcoRI and HindIII (see Figure 1 .18) and pasting a new gene in place of the missing portion by an enzyme called a DNA ligase.
Restriction enzymes cleave double-stranded DNA chains at their specific sites, as typically exemplified for EcoRI and HindIII in Figure 1 .19.
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Stop codon The cleavage leaves a pair of short complementary chains (cohesive ends) which will be linked again with an enzyme, DNA ligase. Ligation also takes place between the cohesive ends that are produced from different double-stranded DNAs, cleaved by the same type of restriction enzyme. Therefore, if the same set of restriction sites were to exist on a plasmid (Figure 1 .20, top) and on a DNA fragment that included the protein-coding region (bottom), the latter would be inserted into the plasmid after cleavage by restriction enzymes, followed by the ligation with DNA ligase (Figure 1 .20).
Large-Scale Production of Engineered Proteins
The complete procedure for obtaining a target protein from the plasmid is illustrated in Figure 1 .21. The plasmid inserted with the protein coding region is introduced into E. coli cells, the cell walls of which are temporarily made permeable to DNAs (competent cells). These transformed cells are cultivated first in suspension, and then transferred onto a cultivation plate with an antibiotic (ampicillin). On the cultivation plate, only those cells that are successfully producing the target protein, together with an ampicillin-resistant protein, can survive and grow to form colonies. Next, one of the colonies is picked up and cultivated in large quantity. After harvesting cells by centrifugation, the cells are lysed by ultrasonic agitation and the insoluble components precipitated by centrifugation. The protein in the supernatant is then purified using column chromatography.
Cell-Free Protein Synthesis and its Automated Process
Protein synthesis using living cells is advantageous for producing a large quantity of any single type of protein, because the transformed cells can be stored and used repeatedly. However, this approach is not appropriate for synthesizing many different types of protein as, usually, it takes a week (or even longer) to obtain a large quantity of transformed cells. Another drawback of the living cell system is that the expressed proteins often form insoluble aggregates (inclusion bodies) inside the host cells, that are not easily resolved. It is also clear that proteins which are toxic to the host cells cannot be synthesized. Nonetheless, these limitations can be avoided if all of the macromolecules that are functioning in the central dogma are extracted from living cells and then assembled in a test tube to conduct protein synthesis. The technique is referred to as cell-free protein synthesis, and proteinsynthesizing mixtures, taken from E. coli for example, are now commercially available.
The procedure for preparing a cell-free protein-synthesizing system (E. coli S30 lysate) is illustrated in Figure 1 .22. The frozen cells are mechanically destroyed and suspended in aqueous solution. After removal of the insoluble components, the soluble portion is centrifuged at 30 000 × g for 30 min. The supernatant is then removed and dialyzed against phosphate-buffered saline to remove any low-molecular-weight components. The remaining solution contains tRNAs, ARSs, ribosomes and other enzymes that are necessary for protein synthesis. Following centrifugation, this protein-synthesizing mixture is known as an S30 mixture.
By adding DNA or mRNA and an amino acid mixture, together with energy sources (ATP and GTP) to the S30 mixture, protein synthesis starts rapidly such that within 30 min the target protein is obtained in quantities of approximately 1 µg ml −1 lysate. As the cell-free synthesis will cease when one of amino acids or NTPs is exhausted, the materials must be fed continuously in order to continue the synthesis. In addition, waste materials such as diphosphates, nucleotide diphosphates (NDPs) and nucleotide monophosphates (NMPs) must be removed from the reaction mixture. This can be accomplished by using a reaction chamber equipped with an autofeeder separated with a semipermeable membrane, as illustrated in Figure 1 .23.
By using such a continuous reaction system the protein yield can be increased to 10-fold that obtained when using a batch system. One of the limiting factors of widespread cell-free synthesis is the cost of S30 or other cell lysates. In order to prepare the S30 lysate, a large quantity of E. coli cells is required, together with processes that are not suited to large-scale production. However, when the cell-free system becomes less cost-prohibitive, it is poised to become a major proteinproducing procedure. Due to the flexibility of the system to synthesize a variety of protein types, the cell-free system is more suited for automated processes than for conventional protein synthesis using living cells.
